Thomas K Equels, CEO and President of AIM ImmunoTech Inc., filed a Form 4 on November 9, 2026, disclosing a purchase of common stock on November 6, 2026.

Key Highlights

  • Reporting person: Thomas K Equels, identified in the filing as Director, CEO and President of AIM ImmunoTech Inc.
  • Transaction: 12,751 shares of common stock acquired (transaction code P) on November 6, 2026.
  • Price paid: $0.158 per share, according to the filing.
  • Resulting ownership: 222,797 shares of common stock beneficially owned directly following the transaction.
  • No derivative securities: Table II of the filing contains no reported derivative security transactions.

Equels Purchase of AIM ImmunoTech Common Stock on November 6, 2026

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Thomas K Equels, who serves as both a Director and as CEO and President of AIM ImmunoTech Inc. (NYSE American: AIM, as identified in the filing's issuer ticker field), acquired 12,751 shares of the company's common stock on November 6, 2026. The transaction was coded "P," indicating an open-market purchase. The price reported per share was $0.158.

Following the reported transaction, the filing states that Equels directly beneficially owned 222,797 shares of AIM ImmunoTech common stock. The filing was signed by Thomas K Equels and submitted on November 9, 2026. No derivative securities transactions were reported in Table II of the filing, and no deemed execution date was noted for the common stock purchase.

The filing was made pursuant to Section 16(a) of the Securities Exchange Act of 1934, which requires officers, directors, and certain shareholders to report changes in their beneficial ownership. No amendment to a prior filing was indicated, and the form was filed by one reporting person.

What Was Disclosed

The filing disclosed a single open-market purchase of 12,751 shares of AIM ImmunoTech common stock by CEO and President Thomas K Equels at $0.158 per share on November 6, 2026, resulting in direct beneficial ownership of 222,797 shares.